MedPath

Succinylcholine

Generic Name
Succinylcholine
Brand Names
Anectine, Quelicin
Drug Type
Small Molecule
Chemical Formula
C14H30N2O4
CAS Number
306-40-1
Unique Ingredient Identifier
J2R869A8YF
Background

Succinylcholine is a depolarizing skeletal muscle relaxant consisting of two molecules of the endogenous neurotransmitter acetylcholine (ACh) linked by their acetyl groups. It has been widely used for over 50 years, most commonly in its chloride salt form, as a means of neuromuscular blockade during intubation and surgical procedures. Its rapid onset and offset, with effects beginning within 60 seconds of intravenous administration and lasting between four to six minutes, make succinylcholine particularly useful in the setting of short medical procedures requiring brief periods of muscle relaxation.

Indication

Succinylcholine is indicated as an adjunct to general anesthesia, to facilitate tracheal intubation, and to provide skeletal muscle relaxation during surgery or mechanical ventilation.

Associated Conditions
-
Associated Therapies
Tracheal Intubation

Mask Ventilation Before and After Neuromuscular Blockade

Phase 4
Completed
Conditions
Anesthesia
Interventions
First Posted Date
2014-09-11
Last Posted Date
2015-04-09
Lead Sponsor
University of Washington
Target Recruit Count
210
Registration Number
NCT02237443
Locations
🇺🇸

Harborview Medical Center, Seattle, Washington, United States

Comparing Intubating Conditions Using Succinylcholine or Rocuronium for Rigid Bronchoscopy

Not Applicable
Suspended
Conditions
Patient Satisfaction
Intubating Conditions
Postoperative Myalgia
Interventions
First Posted Date
2013-11-27
Last Posted Date
2017-04-04
Lead Sponsor
Dr. Horst Schmidt Klinik GmbH
Target Recruit Count
150
Registration Number
NCT01996358
Locations
🇩🇪

Dr. Horst Schmidt Klinik, Wiesbaden, Hessen, Germany

Low Dose Mivacurium vs. Low Dose Succinylcholine for Rigid Bronchoscopy

Not Applicable
Completed
Conditions
Performance With Respiratory Exercise Device
Postoperative Myalgia
Intubating Conditions
Interventions
First Posted Date
2013-10-21
Last Posted Date
2014-07-30
Lead Sponsor
Dr. Horst Schmidt Klinik GmbH
Target Recruit Count
100
Registration Number
NCT01966484
Locations
🇩🇪

Dr. Horst Schmidt Klinik GmbH, Wiesbaden, Germany

Comparison of Surgical Conditions in Cesarean Section Under General Anesthesia With Deep Neuromuscular Blockade Versus Succinylcholine

Phase 4
Completed
Conditions
Cesarean Section
Interventions
First Posted Date
2013-09-13
Last Posted Date
2019-02-11
Lead Sponsor
Charles University, Czech Republic
Target Recruit Count
91
Registration Number
NCT01941628
Locations
🇨🇿

General University Hospital in Prague, Prague, Czechia

Enhancing the Effectiveness of Electroconvulsive Therapy in Severe Depression

Phase 4
Completed
Conditions
Depression
Interventions
First Posted Date
2013-07-24
Last Posted Date
2018-11-14
Lead Sponsor
St Patrick's Hospital, Ireland
Target Recruit Count
138
Registration Number
NCT01907217
Locations
🇮🇪

St Patrick's University Hospital, Dublin, Ireland

Muscle Relaxation for Short Procedures

Not Applicable
Completed
Conditions
Intubating Conditions
Fasciculations
Postoperative Myalgia
Patient Satisfaction
Sore Throat
Interventions
Drug: Rocuronium/Sugammadex
Drug: Succinylcholine
Drug: Rocuronium
First Posted Date
2013-07-18
Last Posted Date
2013-07-18
Lead Sponsor
Dr. Horst Schmidt Klinik GmbH
Target Recruit Count
105
Registration Number
NCT01902641
Locations
🇩🇪

Dr. Horst Schmidt Kliniken, Wiesbaden, Germany

Succinylcholine or Rocuronium for Rigid Bronchoscopy Under General Anesthesia

Phase 4
Terminated
Conditions
Anesthesia
Interventions
First Posted Date
2012-04-18
Last Posted Date
2016-11-03
Lead Sponsor
Hopital Foch
Target Recruit Count
6
Registration Number
NCT01579864
Locations
🇫🇷

Hopital Foch, Suresnes, Ile de France, France

Rapid Sequence Intubation With Magnesium-rocuronium Compared With Succinylcholine - A Randomised Clinical Study

Phase 2
Completed
Conditions
Intubation Conditions
Interventions
Drug: Magnesium perfusion
Drug: Placebo perfusion
Drug: Rocuronium
Drug: Succinylcholine
First Posted Date
2012-04-05
Last Posted Date
2015-07-20
Lead Sponsor
University Hospital, Geneva
Target Recruit Count
280
Registration Number
NCT01571908
Locations
🇨🇭

University Hospital of Geneva, Anesthesia Department, Geneva, Canton of Geneva, Switzerland

🇨🇭

Division of Anaesthesiology, University Hospital of Lausanne (CHUV), Lausanne, Vaud, Switzerland

Optimal Dose of Succinylcholine and Rocuronium for Electroconvulsive Therapy (ECT)

Not Applicable
Completed
Conditions
Neuromuscular Blockade
ECT
Interventions
First Posted Date
2011-09-28
Last Posted Date
2015-06-02
Lead Sponsor
Massachusetts General Hospital
Target Recruit Count
45
Registration Number
NCT01441960
Locations
🇺🇸

Massachusetts General Hospital, Boston, Massachusetts, United States

Effect of Succinylcholine on Patients Using Statins

Not Applicable
Completed
Conditions
Pain
Interventions
First Posted Date
2009-09-30
Last Posted Date
2016-10-03
Lead Sponsor
The Cleveland Clinic
Target Recruit Count
70
Registration Number
NCT00986583
Locations
🇺🇸

Cleveland Clinic Foundation, Cleveland, Ohio, United States

© Copyright 2025. All Rights Reserved by MedPath